
iMed Technologies is a Japanese company developing AI-powered surgical assistance software for neurovascular interventions. Founded by a neurosurgeon with 16 years of experience, the company aims to improve the safety and outcomes of complex brain surgeries. Their core product, 'Neuro-Vascular Assist,' analyzes medical images and provides real-time AI guidance during procedures like angioplasty and coiling. The company leverages deep learning and extensive medical data to address the challenges of precise surgical manipulation, reducing the risk of complications. iMed Technologies has received recognition and funding from various organizations, including the University of Tokyo IPC and NEDO, and has published research in notable journals like the American Journal of Neuroradiology.

iMed Technologies is a Japanese company developing AI-powered surgical assistance software for neurovascular interventions. Founded by a neurosurgeon with 16 years of experience, the company aims to improve the safety and outcomes of complex brain surgeries. Their core product, 'Neuro-Vascular Assist,' analyzes medical images and provides real-time AI guidance during procedures like angioplasty and coiling. The company leverages deep learning and extensive medical data to address the challenges of precise surgical manipulation, reducing the risk of complications. iMed Technologies has received recognition and funding from various organizations, including the University of Tokyo IPC and NEDO, and has published research in notable journals like the American Journal of Neuroradiology.